Answers are grounded in this paper and cite their sources.
Background Consumer-level drug recalls usually require action by individual patients. FDA has public-facing outlets to inform consumers and healthcare professionals about drug safety information including recalls, but consumers may not be aware of them. Prescribers are not notified about which of their patients are affected. The process may lead some patients to stop taking their medications. Aim To leverage the FDA’s Healthy Citizen prototype platform, which provides information about recalls, to automatically notify patients of relevant recalls. Method We developed and evaluated an electronic notification system in the Primary Care and Cardiology practices at a large urban, academic medical center. Using structured interviews, we assessed qualitative feedback on the system and portal messaging from a convenience sample of 9 patients. Results Program Description The healthcare portal scanned the FDA Healthy Citizen Application Programming Interface nightly to detect new recalls, identified patients who had those medications in their electronic health record (EHR) medication list, and sent them a message through the EHR patient portal with a link to a customized FDA information display. Program Evaluation The system was technically functional, but it was not possible to trace a medication prescription from the EHR to specific lot numbers dispensed to that patient by a community pharmacy. Discussion Lack of an accurate electronic audit trail from prescription to dispensed medication precludes clinical deployment of automated drug recall notification.
No takes yet. Share an insight, caveat, or question.
Gadgil et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: